DVAX vs ECL · rev $277.2M vs P/E 35, rev $4.01B
Dynavax Technologies Corporation (DVAX) versus Ecolab Inc (ECL) — a side-by-side from cached financials, not a winner call.
Dynavax Technologies Corporation (DVAX) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Ecolab Inc (ECL) is a specialty chemicals company listed on US.
Latest reported DVAX revenue for 2024-12-31 was $277.2M. Net income was $27.3M. Revenue was up 19.4% from 2023-12-31 to 2024-12-31. DVAX currently screens at market cap $1.82B.
Latest reported ECL revenue for 2024-12-31 was $4.01B. Net income was $2.13B. Revenue was up 0.2% from 2024-09-30 to 2024-12-31. ECL currently screens at market cap $72.05B and trailing P/E 34.6.
DVAX currently screens at market cap $1.82B. ECL currently screens at market cap $72.05B and trailing P/E 34.6.
Not investment advice. Open the DVAX and ECL stock pages for the full models.
Not investment advice.